March 10, 2021 | 8:15 AM
Convalescent plasma strikes out as COVID-19 treatment
The idea is to take blood plasma from people who have recovered from COVID-19 and infuse it into patients with active infections.
The FDA’s credibility is crucial right now as it evaluates potential vaccines for the coronavirus.
The days of journalism’s one-way street of simply producing stories for the public have long been over. Now, it’s time to find better ways to interact with you and ensure we meet your high standards of what a credible media organization should be.